RedoseZepbound is Eli Lilly's brand of tirzepatide approved specifically for weight management, and it has quickly become one of the most talked-about injectables in the GLP-1 era. This guide explains what it is, how the weekly dose schedule works from 2.5 mg up to 15 mg, what the trial data actually showed, and how to keep your shots organized so you never miss or double a dose.
This is an educational overview, not medical advice. Always follow your prescriber's plan and the official labelling.
What Is Zepbound?
Zepbound is a once-weekly subcutaneous injection of tirzepatide, a dual GIP and GLP-1 receptor agonist. Most weight-loss injectables (like semaglutide) act on a single hormone pathway, GLP-1. Tirzepatide activates two: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). Acting on both is thought to be why it produces some of the largest average weight reductions seen with this class of medicine.
It works by slowing how fast your stomach empties, reducing appetite and food intake, and improving how your body handles blood sugar. The result for most people is meaningfully reduced hunger and earlier fullness.
The FDA approved Zepbound in November 2023 for chronic weight management in adults with obesity, or overweight plus at least one weight-related condition such as high blood pressure, high cholesterol, or type 2 diabetes. In December 2024 it gained a second indication: moderate-to-severe obstructive sleep apnea in adults with obesity.
Zepbound vs Mounjaro vs Ozempic
A frequent point of confusion: Zepbound and Mounjaro are the exact same drug, tirzepatide. Lilly sells it under two names because they are approved for different uses, Zepbound for weight and sleep apnea, Mounjaro for type 2 diabetes. The tirzepatide molecule and dose steps are identical.
Ozempic and Wegovy, by contrast, are both semaglutide, a single-pathway GLP-1 agonist from Novo Nordisk. If you are weighing those two against each other, see our Ozempic vs Wegovy comparison. The short version: Zepbound (tirzepatide) and the Wegovy/Ozempic family (semaglutide) are different molecules, and head-to-head data has favored tirzepatide for average weight loss.
The Zepbound Dose Schedule
Zepbound is titrated, meaning you start low and step up slowly. This gives your gut time to adapt and keeps side effects manageable.
| Phase | Dose | Duration |
|---|---|---|
| Starting | 2.5 mg weekly | 4 weeks |
| First maintenance | 5 mg weekly | 4+ weeks |
| Step up (if needed) | 7.5 mg weekly | 4+ weeks |
| Step up (if needed) | 10 mg weekly | 4+ weeks |
| Step up (if needed) | 12.5 mg weekly | 4+ weeks |
| Maximum | 15 mg weekly | ongoing |
Key points:
- The 2.5 mg starting dose is not a treatment dose, it exists only to ease you in. Expect to move to 5 mg after the first month.
- Dose increases happen no faster than every 4 weeks. If side effects are rough at a given step, your prescriber may keep you there longer before going up.
- The approved maintenance doses are 5, 10, and 15 mg. Many people do well staying at 5 or 10 mg rather than always climbing to the top.
If you use a multi-dose vial and syringe rather than the single-dose pen, you will need to convert your milligram dose into syringe units. Our GLP-1 dose calculator has the full semaglutide and tirzepatide dose ladders built in as presets, and the reconstitution calculator handles the mixing math.
How Much Weight Loss to Expect
The pivotal SURMOUNT-1 trial studied adults with obesity but without diabetes over 72 weeks. Average results, on top of a reduced-calorie diet and increased activity:
- ~15% of body weight at the 5 mg dose
- ~19.5% at 10 mg
- ~20.9% at 15 mg
For a 250 lb starting weight, 21 percent is roughly 52 lb. These are averages, some people lose more, some less, and weight tends to return if treatment stops without lasting lifestyle change. Progress is also rarely linear, which is exactly why tracking your weekly trend matters more than any single weigh-in.
Side Effects and How to Manage Them
The most common Zepbound side effects are gastrointestinal and usually mild to moderate:
- Nausea
- Diarrhea
- Vomiting
- Constipation
- Indigestion and burping
These typically peak right after a dose increase and fade as you adjust, which is the whole reason for slow titration. Practical steps that help: eat smaller portions, stop when full, reduce greasy and very sweet foods, and stay hydrated.
Serious but rarer risks include pancreatitis, gallbladder problems, and low blood sugar (especially if combined with insulin or sulfonylureas). Zepbound carries a boxed warning about thyroid C-cell tumors seen in rodents; it should not be used by people with a personal or family history of medullary thyroid carcinoma or MEN2. Discuss your full history with your prescriber.
Injecting Zepbound: Timing and Sites
- Once a week, same day, any time of day, with or without food.
- You can move your injection day if needed, as long as it has been at least 72 hours since your last dose.
- Inject subcutaneously into the abdomen, thigh, or upper arm.
- Rotate sites each week to avoid irritation and lumps under the skin.
Site rotation is easy to lose track of by week six. The Redose app keeps a visual body-map history and suggests the next site automatically, so you are not guessing where last week's shot went.
Tracking Your Zepbound Protocol
A weekly medication is deceptively easy to mismanage: it is only 52 shots a year, but missing one, doubling up after a late dose, or losing track of which titration week you are on all happen more often than you would think. A few things worth logging every week:
- The shot itself, dose, day, and injection site, in one tap.
- Side effects, so you and your prescriber can see whether nausea tracks with dose steps.
- Weight trend, viewed as a moving average rather than daily noise.
- Your titration week, so the next step-up is never a surprise.
Redose was built for exactly this. Set your Zepbound schedule once and it generates the weekly reminders, pre-fills your dose, rotates injection sites, and charts your weight trend, the same way it does for the dedicated Zepbound tracker, Wegovy tracker, and semaglutide tracker. For the dosing arithmetic, the GLP-1 dose calculator and vial duration calculator cover units-to-draw and when to reorder.
The Bottom Line
Zepbound (tirzepatide) is a dual-hormone, once-weekly injection with some of the strongest average weight-loss results in its class, titrated from 2.5 mg up to a maximum of 15 mg. Most side effects are gastrointestinal and ease with slow dose increases. It is a prescription medicine with real risks, so it belongs in a plan supervised by a clinician, and tracked consistently so you can see what is actually working.